Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Interest Expenses (2020 - 2022)

Maxcyte has reported Interest Expenses over the past 3 years, most recently at $11000.0 for Q4 2022.

  • Quarterly Interest Expenses changed N/A to $11000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $11000.0 through Sep 2023, down 90.52% year-over-year, with the annual reading at $127000.0 for FY2022, 87.84% down from the prior year.
  • Interest Expenses was $11000.0 for Q4 2022 at Maxcyte, down from $116000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $742300.0 in Q1 2021 and troughed at $11000.0 in Q4 2022.
  • The 3-year median for Interest Expenses is $213950.0 (2020), against an average of $235000.0.
  • The largest YoY upside for Interest Expenses was 9.8% in 2021 against a maximum downside of 91.99% in 2021.
  • A 3-year view of Interest Expenses shows it stood at $280600.0 in 2020, then rose by 2.99% to $289000.0 in 2021, then crashed by 96.19% to $11000.0 in 2022.
  • Per Business Quant, the three most recent readings for MXCT's Interest Expenses are $11000.0 (Q4 2022), $116000.0 (Q3 2022), and $289000.0 (Q3 2021).